MedTrace Logo

Study of Organ Perfusion With Custodiol-N Solution Compared With Custodiol Solution in Heart Transplantation

NCT02869022 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2020-01-18

No results posted yet for this study

Summary

The objective of this investigation is to demonstrate non-inferiority in outcome of Custodiol-N against Custodiol in heart transplantation.

Conditions

Interventions

DRUG

Custodiol-N

comparison of two Solutions, Custodiol-N versus Custodiol, for organ Perfusion in heart transplantation

DRUG

Custodiol

comparison of two Solutions, Custodiol-N versus Custodiol, for organ Perfusion in heart transplantation

PROCEDURE

organ perfusion for heart transplantation

Sponsors & Collaborators

  • Dr. F. Köhler Chemie GmbH

    lead INDUSTRY

Principal Investigators

  • Gabor Szabo, Prof. Dr. · Abt. Herzchirugie, Universitätsklinikum Heidelberg

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2019-09-02
Completion
2019-09-02

Countries

  • Austria
  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02869022 on ClinicalTrials.gov